iBio (IBIO) EBT (2010 - 2026)

iBio (IBIO) has reported EBT for 17 consecutive years, with -$10.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBT fell 105.33% year-over-year to -$10.6 million in Q2 2026; TTM through Jun 2026 was -$33.0 million, a 79.81% decrease from a year earlier, with the FY2026 full-year figure at -$33.0 million, down 79.81% from the prior year.
• EBT was -$10.6 million for Q2 2026 at iBio, down from -$7.7 million in the prior quarter.
• Over five years, EBT peaked at -$2.6 million in Q1 2024 and troughed at -$10.6 million in Q2 2026.
• A 5-year average of -$6.3 million and a median of -$5.4 million in 2025 frame the typical range for EBT.
• Across the five-year window, EBT surged 58.03% in 2024 and plunged 106.07% in 2025, its largest moves.
• Over 5 years, EBT stood at -$10.6 million in 2022, then soared by 57.51% to -$4.5 million in 2023, then increased by 2.76% to -$4.4 million in 2024, then sank by 106.07% to -$9.0 million in 2025, then retreated by 17.88% to -$10.6 million in 2026.
• The last three EBT figures came in at -$10.6 million (Q2 2026), -$7.7 million (Q1 2026), and -$9.0 million (Q4 2025), per Business Quant data.